An absence of CCR5 on donor cells results in acceleration of acute graft-vs-host disease
- 31 March 2004
- journal article
- Published by Elsevier in Experimental Hematology
- Vol. 32 (3) , 318-324
- https://doi.org/10.1016/j.exphem.2003.12.003
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Acceleration of idiopathic pneumonia syndrome (IPS) in the absence of donor MIP-1α (CCL3) after allogeneic BMT in miceBlood, 2003
- Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reactionNature Immunology, 2003
- Donor-type CD4+CD25+ Regulatory T Cells Suppress Lethal Acute Graft-Versus-Host Disease after Allogeneic Bone Marrow TransplantationThe Journal of Experimental Medicine, 2002
- Role of anti-tumor necrosis factor-?? in ischemia/reperfusion injury in isolated rat liver in a blood-free environmentTransplantation, 2002
- The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethalityBlood, 2002
- Antibodies to CD40 induce a lethal cytokine cascade after syngeneic bone marrow transplantationTransplantation and Cellular Therapy, 2001
- Active participation of CCR5+CD8+ T lymphocytes in the pathogenesis of liver injury in graft-versus-host diseaseJournal of Clinical Investigation, 1999
- Donor-derived interferon gamma is required for inhibition of acute graft-versus-host disease by interleukin 12.Journal of Clinical Investigation, 1998
- Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice.Journal of Clinical Investigation, 1998
- Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease.The Journal of Experimental Medicine, 1992